Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results
Document Details
Form
Filing Date
Apr 11, 2024
Document Date
Apr 11, 2024
Form Description
Additional proxy soliciting materials - definitive
Filing Group
Proxy Filings
Company
Dianthus Therapeutics
Issuer
DIANTHUS THERAPEUTICS, INC. /DE/